Cempra (CEMP) Announces Receipt of Positive FDA AdCom Vote on Solithromycin in CABP
Tweet Send to a Friend
Cempra, Inc. (Nasdaq: CEMP) announced that the majority of the U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
